# Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers

> **NCT01723891** · PHASE1 · COMPLETED · sponsor: **Hyundai Pharmaceutical Co., LTD.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Surfolase capsule
- **DRUG:** HT-002-01

## Key facts

- **NCT ID:** NCT01723891
- **Lead sponsor:** Hyundai Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01723891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01723891, "Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01723891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*